Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Maintaining a healthy blood sugar level can reduce your disease risk and give you more energy. These 15 habits help keep ...

Vitamin D sits at the intersection of bone, muscle, immune health, and overall metabolism. Researchers have asked a simple ...

Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.

Upending previous research, study finds no evidence of status-quo bias favoring standard care when two or more appropriate alternatives are presented.

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

The American Academy of Pediatrics declined to recommend routine use of leucovorin for children with autism spectrum disorder ...